SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BarbaraT who wrote (82505)7/8/1999 10:50:00 AM
From: changedmyname  Read Replies (1) of 119973
 
ESPS-----> OVERLOOKED! Coverage Starts this next MONDAY. ADBE owns 32% of this company... and it's profitable. Great underwriters: H&Q, BancBoston, and Scwab to name a few.

ESPS is the little white pill for companies showing
symptoms of time-consuming regulatory filings. ESPS's
(Electronic Submission Publishing Systems)
foundation software, CoreDossier, helps
pharmaceutical, biotechnology, and other companies
electronically generate the large documents (up to
500,000 pages) required by regulatory agencies. Users
pull data from other databases and compile it into
reports that can be edited, published, distributed, and
archived. Glaxo Wellcome, Hoechst, and
Rhone-Poulenc account for about half of ESPS's sales.
ESPS offers related compliance services and continues
to expand into utilities, chemicals, and other
document-intensive markets. Software firm Adobe
Systems owns 32% of ESPS.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext